e-learning
resources
Glasgow 2004
Monday 06.09.2004
Community acquired and nosocomial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community acquired pneumonia (CAP) and PSI mortality risk stratification
C. N. Meyer, S. Novovic (Copenhagen, Denmark)
Source:
Annual Congress 2004 - Community acquired and nosocomial pneumonia
Session:
Community acquired and nosocomial pneumonia
Session type:
Thematic Poster Session
Number:
2547
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. N. Meyer, S. Novovic (Copenhagen, Denmark). Community acquired pneumonia (CAP) and PSI mortality risk stratification. Eur Respir J 2004; 24: Suppl. 48, 2547
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Community acquired pneumonia (CAP) mortality and biomarkers
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Community acquired pneumonia (CAP). Mortality prediction using the BTS-rule
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004
Community acquired pneumonia (CAP) 30 days mortality and biomarkers
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Mortality and prognostic factors of necrotizing community acquired pneumonia (NCAP) in a general hospital
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007
COPD is an independent risk factor for mortality in community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Risk factors for ICU acquired pneumonia
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008
3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016
Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Biomarkers and community acquired pneumonia (CAP) severity
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Biomarkers and community acquired pneumonia (CAP) severity
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept